Monday, July 24, 2017 12:27:55 AM
But I would still like to see one or more patients convert before their 6 months are up - when was our last PR on a new conversion? The company was supposed to gather more recent stats for the FDA on the current SOC effectiveness. If recent SOC stats indicate more success than in the past, it would be advantageous if the scaffold stats were even more dramatic.
I added a few shares last week lowering my cost basis to 4.69. While I was glad to add at a great price, I'm still under water. But I'm staying long, waiting for the next positive PR.
There are a number of conditions that have no effective treatment - ALS and Alzheimer's come to mind. SPI is another. If we can get this trial successfully concluded (I think we will), then imo 2.20 will be a gift. On the other hand, if the trial fails, then 2.20 is no gift!
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM